FDA drug approval backlog increases by 15% within 6 months

Market overview

Makary's departure disrupts ongoing efforts to streamline clinical trials and regulatory processes. Competing priorities among potential successors and Senate confirmation delays will hinder approvals, exacerbating existing backlogs.

regulatory prediction market

Implied probability (Yes)

70%

Source: user-generated

More regulatory markets

• Logistics firm loses aviation contract within one year of bust — 68% Yes
• UK online gambling revenue drops 8% in Q4 2026 due to new checks — 72% Yes
• EU financial regulators adopt Basel III final rules ahead of US by 2027 — 60% Yes
• Brazil’s central bank tightens financial oversight within 6 months — 80% Yes
• FTC to issue formal safety guidelines for AI by Q2 2027 — 75% Yes
• Congress holds hearings on FDA leadership vacuum by year-end — 75% Yes
• OpenAI faces regulatory scrutiny over AI misalignment by 2027 — 60% Yes
• Maveron faces formal sanctions from SEC by 2027-Q1 — 72% Yes

Browse all regulatory markets →